文献速递肝病消化道肿瘤与早癌

B淋巴细胞限制衰老驱动的纤维化消退并促进小鼠肝损伤中的肝癌发生

B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
PubMed 文献 · Hepatology · 2018-03-25

该研究在Mdr2敲除小鼠炎症相关肝癌模型中,通过基因敲除(Rag2-/-Mdr2-/-和μMt-Mdr2-/-小鼠)或抗体清除(抗CD20或抗CD4/CD8)去除适应性免疫,发现B和T淋巴细胞分泌促纤维化TNFα等促炎细胞因子,浸润肝脏并抑制HSC衰老、促进纤维化和肝癌发生;仅清除CD20+B细胞(而非CD4+/CD8+T细胞)可促进衰老介导的纤维化消退并抑制促肿瘤TNFα/NF-κB通路;人类HCC中浸润B细胞与肿瘤侵袭性增加和无病生存期缩短相关。

要点

  • Mdr2-/-小鼠慢性纤维化胆管炎中活化的B和T淋巴细胞浸润肝脏并分泌TNFα等促炎细胞因子。
  • 基因去除适应性免疫(Rag2-/-Mdr2-/-和μMt-Mdr2-/-)强烈抑制HSC活化和细胞外基质沉积,促进HSC向细胞衰老转变。
  • 仅清除CD20+B细胞(而非CD4+/CD8+T细胞)可促进衰老介导的纤维化消退并抑制促肿瘤TNFα/NF-κB通路。

核心结论

  • 适应性免疫通过调节炎症 innate 成分和限制HSC衰老程度,在慢性损伤中维持肝纤维化并促进HCC生长。
  • 针对B细胞靶向设计的疗法可能是肝纤维化的有效策略。

研究设计与样本

  • 研究使用Mdr2敲除(Mdr2-/-)小鼠,一种炎症相关癌症模型,通过基因方式(Rag2-/-Mdr2-/-和μMt-Mdr2-/-小鼠)或体内使用淋巴细胞特异性清除抗体(抗CD20或抗CD4/CD8)诱导适应性免疫消除。

主要发现

  • 在Mdr2-/-小鼠慢性纤维化胆管炎期间,分泌促纤维化TNFα和其他促炎细胞因子的活化B和T淋巴细胞浸润肝脏。
  • 在Rag2-/-Mdr2-/-和μMt-Mdr2-/-小鼠中,淋巴细胞消除强烈抑制肝星状细胞(HSC)活化和细胞外基质沉积,增强HSC向细胞衰老转变。
  • 淋巴细胞缺乏改变肝内代谢/氧化状态,导致巨噬细胞极化为抗炎M2表型。
  • 在Rag2-/-Mdr2-/-小鼠中,肝癌发生显著受抑制,与TNFα/NF-κB通路活化降低相关。
  • 在Mdr2-/-小鼠中清除CD20+B细胞(而非CD4+/CD8+T细胞)促进衰老介导的纤维化消退并抑制促肿瘤TNFα/NF-κB通路。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Hepatocellular carcinoma (HCC) is a frequent neoplasia and a leading cause of inflammation-related cancer mortality. Despite that most HCCs arise from persistent inflammatory conditions, pathways linking chronic inflammation to cancer development are still incompletely elucidated. We dissected the role of adaptive immunity in the Mdr2 knockout (Mdr2-/- ) mouse, a model of inflammation-associated cancer, in which ablation of adaptive immunity has been induced genetically (Rag2-/- Mdr2-/- and μMt-Mdr2-/- mice) or with in vivo treatments using lymphocyte-specific depleting antibodies (anti-CD20 or anti-CD4/CD8). We found that activated B and T lymphocytes, secreting fibrogenic tumor necrosis factor alpha (TNFα) and other proinflammatory cytokines, infiltrated liver of the Mdr2-/- mice during chronic fibrosing cholangitis. Lymphocyte ablation, in the Rag2-/- Mdr2-/- and μMt-Mdr2-/- mice, strongly suppressed hepatic stellate cell (HSC) activation and extracellular matrix deposition, enhancing HSC transition to cellular senescence. Moreover, lack of lymphocytes changed the intrahepatic metabolic/oxidative state, resulting in skewed macrophage polarization toward an anti-inflammatory M2 phenotype. Remarkably, hepatocarcinogenesis was significantly suppressed in the Rag2-/- Mdr2-/- mice, correlating with reduced TNFα/NF-κB (nuclear factor kappa B) pathway activation. Ablation of CD20+ B cells, but not of CD4+ /CD8+ T cells, in Mdr2-/- mice, promoted senescence-mediated fibrosis resolution and inhibited the protumorigenic TNFα/NF-κB pathway. Interestingly, presence of infiltrating B cells correlated with increased tumor aggressiveness and reduced disease-free survival in human HCC. CONCLUSION: Adaptive immunity sustains liver fibrosis (LF) and favors HCC growth in chronic injury, by modulating innate components of inflammation and limiting the extent of HSC senescence. Therapies designed for B-cell targeting may be an effective strategy in LF. (Hepatology 2018;67:1970-1985).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Faggioli F, Palagano E, Di Tommaso L, et al. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury. Hepatology. 2018. PMID: 29105104. doi:10.1002/hep.29636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。